Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health.

Australia / epidemiology Estrogen Replacement Therapy / adverse effects Estrogens / adverse effects Female Humans Longitudinal Studies Melanoma / chemically induced Menopause Skin Neoplasms / chemically induced Women's Health Melanoma, Cutaneous Malignant
Estrogen Melanoma Menopausal hormone therapy Progestogen

Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
06 2022
Historique:
received: 19 11 2021
revised: 11 01 2022
accepted: 12 01 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 18 5 2022
Statut: ppublish

Résumé

New evidence on the association between use of menopausal hormone therapy and increased risk of cutaneous melanoma (CM) is emerging. In the Australian Longitudinal Study on Women's Health, we followed 18,850 postmenopausal women for a median of 13.2 years, and observed 356 incident CMs. We found an indication of an association between use of unopposed oestrogen therapy and CM risk (hazard ratio (HR) 1.26; 95% confidence interval (CI) 0.98, 1.61), and no association between use of oestrogen-progestin therapy and CM risk (HR 0.99; 95% CI 0.37, 2.67). More studies are needed to elucidate the potential impact of different types of hormone therapy on CM risk.

Identifiants

DOI: 10.1016/j.maturitas.2022.01.004 PMID: 35550702
pubmed: 35550702
pii: S0378-5122(22)00016-0
doi: 10.1016/j.maturitas.2022.01.004
pii:
doi:

Substances chimiques

Estrogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-3

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Edoardo Botteri (E)

Department of Research, Cancer Registry of Norway, Oslo, Norway; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway. Electronic address: edoardo.botteri@kreftregisteret.no.

Zhiwei Xu (Z)

NHMRC Centre of Research Excellence on Women and Non-communicable Diseases (CRE WaND), School of Public Health, University of Queensland, Brisbane, Australia.

Nathalie C Støer (NC)

Department of Research, Cancer Registry of Norway, Oslo, Norway; Norwegian Research Centre for Women's Health, Women's Clinic, Oslo University Hospital, Oslo, Norway.

Gita D Mishra (GD)

NHMRC Centre of Research Excellence on Women and Non-communicable Diseases (CRE WaND), School of Public Health, University of Queensland, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Hormonothérapie substitutive › Oestrogénothérapie substitutive › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Hormones › Oestrogènes › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études longitudinales › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Développement sexuel › Climatère › Ménopause › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › Menopausal hormone therapy and melanoma risk...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé des femmes › Menopausal hormone therapy and melanoma risk...